10-QPeriod: Q1 FY2015

EIDP, Inc. Quarterly Report for Q1 Ended Mar 31, 2015

Filed April 21, 2015For Securities:CTA-PBCTA-PA

Summary

E. I. du Pont de Nemours and Company (DuPont) reported lower net sales and net income for the first quarter of 2015 compared to the same period in 2014. Net sales decreased by 9% to $9.2 billion, primarily due to a significant negative impact from currency fluctuations (6%) and the absence of sales from portfolio changes (2%). Net income attributable to DuPont fell by 28% to $1,031 million, or $1.13 per diluted share, from $1,439 million, or $1.54 per diluted share, in the prior year. This decline was driven by lower segment pre-tax operating income and higher income taxes. The company highlighted significant progress in its global redesign initiative, expecting cost savings to reach $0.40 per share in 2015. A major development is the impending separation of the Performance Chemicals segment, which is expected to be completed on July 1, 2015, creating a new company named The Chemours Company. DuPont anticipates receiving approximately $4 billion in dividend proceeds from Chemours prior to separation, with plans to return substantially all of this amount to shareholders through share repurchases. The company also reported a notable increase in other income, driven by foreign exchange gains, and continued to manage market risks through derivative instruments.

Financial Statements
Beta
Revenue$7.84B
Cost of Revenue$4.52B
Gross Profit$3.32B
R&D Expenses$479.00M
SG&A Expenses$1.22B
Operating Expenses$7.77B
Operating Income$1.94B
Interest Expense$84.00M
Net Income$1.03B
EPS (Basic)$1.13
EPS (Diluted)$1.13
Shares Outstanding (Basic)906.84M
Shares Outstanding (Diluted)913.82M

Key Highlights

  • 1Net sales for Q1 2015 were $9.2 billion, a 9% decrease from $10.1 billion in Q1 2014, largely impacted by a 6% negative currency effect.
  • 2Net income attributable to DuPont decreased by 28% to $1,031 million ($1.13 per diluted share) from $1,439 million ($1.54 per diluted share) year-over-year.
  • 3The company is on track to complete the spin-off of its Performance Chemicals segment (to become The Chemours Company) on July 1, 2015.
  • 4DuPont expects to receive approximately $4 billion in dividends from Chemours prior to separation, intending to return most of it to shareholders via buybacks.
  • 5Cost savings from the global redesign initiative are projected to increase to $0.40 per share in 2015, with expected run-rate savings of $1 billion by Q4 2015.
  • 6Other income, net, significantly increased to $198 million from $17 million, driven by foreign exchange gains and litigation settlements.
  • 7The company's cash, cash equivalents, and marketable securities decreased to $3.7 billion from $7.0 billion due to funding seasonal working capital needs.

Frequently Asked Questions

DuPont experienced a decline in both net sales and net income. Net sales decreased by 9% to $9.2 billion, primarily due to negative currency impacts. Net income attributable to DuPont fell by 28% to $1,031 million, or $1.13 per diluted share. This was largely attributed to lower segment operating income and higher taxes.

DuPont announced its intention to separate the Performance Chemicals segment, which will be named The Chemours Company. The separation is expected to be completed on July 1, 2015. The company anticipates receiving approximately $4 billion in dividends from Chemours prior to the separation.

DuPont is executing a global redesign initiative aimed at improving productivity and reducing costs. The company expects cost savings to contribute $0.40 per share in 2015 and anticipates reaching $1 billion in run-rate savings by the end of 2015. Selling, general, and administrative expenses (SG&A) decreased year-over-year due to these savings and lower sales commissions.

Other income, net, saw a substantial increase to $198 million in Q1 2015 from $17 million in Q1 2014. This rise was primarily driven by significant pre-tax exchange gains on foreign currency contracts due to a strengthening U.S. dollar, as well as gains from litigation settlements and asset sales.